Ads
related to: Acute Myeloid Leukemia- Safety
Learn More About Well Characterized
Safety Profile.
- Dosing & Monitoring
Twice Daily
Oral Dosing.
- Efficacy
Durable Complete Remissions
for R/R AML Patients.
- Mechanism of Action
Inhibits Mutant IDHI and
Restores Myeloblast Differentiation
- Safety
Search results
Aileron Therapeutics (NASDAQ:ALRN) Announces Earnings Results, Misses Estimates By $0.72 EPS
ETF DAILY NEWS· 5 days agoAileron Therapeutics (NASDAQ:ALRN – Get Free Report) announced its quarterly earnings data on Monday. The company reported ($0.86) EPS for the quarter, missing the consensus estimate of ($0.14 ...
Brokerages Set Kura Oncology, Inc. (NASDAQ:KURA) Target Price at $27.94
ETF DAILY NEWS· 5 days agoKura Oncology, Inc. (NASDAQ:KURA – Get Free Report) has received a consensus rating of “Moderate Buy” from the seven brokerages that are presently covering the firm, Marketbeat.com reports.
MEI Pharma (NASDAQ:MEIP) Now Covered by Analysts at StockNews.com
ETF DAILY NEWS· 3 days agoStockNews.com assumed coverage on shares of MEI Pharma (NASDAQ:MEIP – Free Report) in a report issued on Thursday. The brokerage issued a buy rating on the stock. A number of other research ...
Remembering the life of Ila Quirion
Bangor Daily News· 7 days agoIla Mae (Clewley) Quirion, 92, wife of the late Wardell (Delly) Quirion, peacefully passed away May 10, 2024, at her daughter's home in Lexington, VA. She attended Bangor High School and was ...
Actinium Pharmaceuticals, Inc. (NYSEAMERICAN:ATNM) Receives $25.60 Consensus Target Price from...
ETF DAILY NEWS· 3 days agoShares of Actinium Pharmaceuticals, Inc. (NYSEAMERICAN:ATNM – Get Free Report) have earned an average rating of “Buy” from the six brokerages that are presently covering the firm, MarketBeat ...
